# Celiprolol Versus Ditiazem for the Prevention of Postoperative Cardiac Arrythmias in Thoracic Surgery

> **NCT03752931** · PHASE2 · UNKNOWN · sponsor: **Abderrahmane Mami Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Postoperative Cardiac Complication

## Interventions

- **DRUG:** Celiprolol
- **DRUG:** Diltiazem

## Key facts

- **NCT ID:** NCT03752931
- **Lead sponsor:** Abderrahmane Mami Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12
- **Primary completion:** 2019-12
- **Final completion:** 2020-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2018-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03752931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03752931, "Celiprolol Versus Ditiazem for the Prevention of Postoperative Cardiac Arrythmias in Thoracic Surgery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03752931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*